Articles published in Journal of Stem Cell Research & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Stem Cell Research & Therapy has got h-index 33, which means every article in Journal of Stem Cell Research & Therapy has got 33 average citations.
Following are the list of articles that have cited the articles published in Journal of Stem Cell Research & Therapy.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
22 | 58 | 59 | 65 | 23 | 13 | 36 | 34 | 49 | 63 | 101 | 62 | 44 | 26 |
Research, Review articles and Editorials |
2 | 4 | 1 | 2 | 12 | 12 | 29 | 28 | 44 | 56 | 80 | 48 | 12 | 19 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
20 | 54 | 58 | 63 | 11 | 1 | 7 | 6 | 5 | 7 | 21 | 14 | 32 | 6 |
Conference proceedings |
10 | 40 | 12 | 37 | 0 | 0 | 145 | 138 | 95 | 63 | 154 | 72 | 54 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
522 | 678 | 761 | 838 | 697 | 626 | 613 | 599 | 538 | 478 | 262 | 142 | 31 | 69 |
Journal total citations count | 6793 |
Journal impact factor | 1.64 |
Journal 5 years impact factor | 1.70 |
Journal cite score | 11.56 |
Journal h-index | 33 |
Highly efficient and marker-free genome editing of human pluripotent stem cells by CRISPR-Cas9 RNP and AAV6 donor-mediated homologous …
AAV integration in human hepatocytes
Therapy Development by Genome Editing of Hematopoietic Stem Cells
Gene editing on center stage
IRF and STAT transcription factors-from basic biology to roles in infection, protective immunity, and primary immunodeficiencies
Global transcriptional response to CRISPR/Cas9-AAV6-based genome editing in CD34+ hematopoietic stem and progenitor cells
Site-specific gene editing of human hematopoietic stem cells for X-linked hyper-IgM syndrome
Gene editing and CRISPR in the clinic: current and future perspectives
Gene therapy targeting haematopoietic stem cells for inherited diseases: progress and challenges
CRISPR-Cas9 based genome editing for defective gene correction in humans and other mammals
Gene correction for SCID-X1 in long-term hematopoietic stem cells
Precise gene editing preserves hematopoietic stem cell function following transient p53-mediated DNA damage response
A new class of medicines through DNA editing
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
Comparative Effectiveness Research: A Pharmaceutical Industry Perspective on Outlook, Dilemmas, and Controversies
Estimates for quality of life loss due to Respiratory Syncytial Virus
Perceptions of the impact of disability and impairment on health, quality of life and capability
Road to stemness in hepatocellular carcinoma
Health-related quality of life measures for a costeffectiveness analysis of ischemic stroke therapies
Glioblastoma Stem Cells and Their Microenvironment